Guidance

Tetanus: the green book, chapter 30

Tetanus immunisation information for public health professionals, including updates.

From:
UK Health Security Agency
Published
20 March 2013
Last updated
6 June 2022 — See all updates

Documents

Tetanus: the green book, chapter 30

Ref: PHE publications gateway number 2019226

PDF, 160 KB, 15 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This edition includes updates on:

  • epidemiology of tetanus
  • management of tetanus prone wounds
  • correct dose of immunoglobulin for prevention of tetanus
  • use of immunoglobulins for the treatment of clinical tetanus

Tetanus is an acute disease caused by the action of tetanus toxin, released following infection by the bacterium Clostridium tetani.

In November 2018 revised guidance for healthcare professionals on the use of immunoglobulins for the treatment of clinical tetanus and the management of tetanus prone wounds was issued.

Chapter 30 update patches.

Updates to this page

Published 20 March 2013
Last updated 6 June 2022 + show all updates

  1. Update the telephone numbers for Bio Products Laboratory.

  2. Added correction to the Scotland supply section.

  3. Added the revised chapter to include updates on the epidemiology and management of wounds and immunoglobulins.

  4. Updated advice on management of exposure prone wounds and supplies of immunoglobulin.

  5. Added link to revised guidance for health professionals.

  6. Added link to interim guidance.

  7. Updated the Body text to include a link to National Archives (chapter update patches) and NHS Choices.

  8. First published.

Sign up for emails or print this page

Related content